
Episode 32: ARCH Venture Partners' Bob Nelsen
BioVenture VoiCes with Chris Garabedian
00:00
Biotech's empirical nature and AI's potential
Bob emphasizes biotech remains empirical and argues AI plus data must systematize biology to reduce costs.
Play episode from 48:18
Transcript


